Viridian Therapeutics, Inc. (VRDN)
28.35
+1.16
(+4.27%)
USD |
NASDAQ |
Mar 25, 16:00
28.37
+0.02
(+0.07%)
After-Hours: 20:00
Viridian Therapeutics Total Liabilities (Quarterly) : 177.25M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 2.274M |
| Plus Therapeutics, Inc. | 12.33M |
| Nutriband, Inc. | 0.8702M |
| Immunovant, Inc. | 66.26M |
| Definium Therapeutics, Inc. | 107.77M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 899.42M |
| Shareholders Equity (Quarterly) | 722.17M |
| Debt to Equity Ratio | 0.0702 |
| Current Ratio | 12.65 |
| Net Debt Paydown Yield | -0.17% |